
Join to view full profile
3300 Webster StSte 509Oakland, CA 94609
Phone+1 510-839-2937
Fax+1 510-452-2152
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ani Tajirian, MD is a board certified dermatologist in Oakland, California. She is currently licensed to practice medicine in California, Vermont, and New Jersey.
Education & Training
University of Vermont Medical CenterFellowship, Micrographic Surgery and Dermatologic Oncology, 2011 - 2012
Rutgers New Jersey Medical SchoolResidency, Dermatology, 2008 - 2011
Rhode Island Hospital/Brown University HealthInternship, Internal Medicine, 2007 - 2008
The Warren Alpert Medical School of Brown UniversityClass of 2007
Certifications & Licensure
CA State Medical License 2012 - 2027
CA State Medical License 2012 - 2025
NJ State Medical License 2008 - 2012
VT State Medical License 2011 - 2012
RI State Medical License 2007 - 2008
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EMA, Modernizing Medicine, Inc., 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EMA Mobile, Modernizing Medicine, Inc., 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EMA, Modernizing Medicine, Inc., 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- 3 citationsCentral Forehead Reconstruction with a Simple Primary Vertical Linear Closure.Ani Tajirian, Michelle Tsui
The Journal of Clinical and Aesthetic Dermatology. 2016-08-01 - 6 citationsCicatricial Ectropion With Topical 5% Fluorouracil Cream.Michelle Tsui, Ani L. Tajirian
Dermatologic Surgery. 2016-08-01 - 4 citationsEyebrow reconstruction after removal of melanoma in situ.Ani L. Tajirian, Christopher B. Yelverton, Glenn D. Goldman
Dermatologic Surgery. 2013-09-01









